Takayuki Saito

The Prediction of Response to Galantamine Treatment in Patients with Mild to Moderate Alzheimer’s Disease

T. Ohnishi, Nami Sugiyama, Y. Sakiyama, 2014, Current Alzheimer research.

Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia

N. Takahashi, Takayuki Saito, Masayoshi Takahashi, 2013, Neuropsychiatric disease and treatment.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo-controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's disease

A. Homma, Y. Yoshiyama, Yu Nakamura, 2019, Alzheimer's & dementia.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

Jan van den Berg, H. Heidbuchel, S. Connolly, 2022, Lancet.